Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (unaudited)

v3.23.2
Condensed Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2021 $ 384,050 $ 1 $ 525,400   $ (141,351)
Beginning balance, Shares at Dec. 31, 2021   58,010,823      
Stock-based compensation expense 3,342   3,342    
Vesting of early exercised stock options 51   51    
Unrealized loss on investments in marketable securities (309)     $ (309)  
Net loss (25,835)       (25,835)
Ending balance at Mar. 31, 2022 361,299 $ 1 528,793 (309) (167,186)
Ending balance, Shares at Mar. 31, 2022   58,010,823      
Beginning balance at Dec. 31, 2021 384,050 $ 1 525,400   (141,351)
Beginning balance, Shares at Dec. 31, 2021   58,010,823      
Net loss (51,771)        
Ending balance at Jun. 30, 2022 338,456 $ 1 532,610 (1,033) (193,122)
Ending balance, Shares at Jun. 30, 2022   58,211,192      
Beginning balance at Mar. 31, 2022 361,299 $ 1 528,793 (309) (167,186)
Beginning balance, Shares at Mar. 31, 2022   58,010,823      
Stock-based compensation expense 3,360   3,360    
Common stock shares issued upon early exercise of options 13   13    
Stock options exercised, shares   43,945      
Common stock issued under ESPP, Shares   207,137      
Common stock issued under ESPP 414   414    
Vesting of early exercised stock options 30   30    
Repurchase of unvested early exercised stock options, Shares   50,713      
Unrealized loss on investments in marketable securities (724)     (724)  
Net loss (25,936)       (25,936)
Ending balance at Jun. 30, 2022 338,456 $ 1 532,610 (1,033) (193,122)
Ending balance, Shares at Jun. 30, 2022   58,211,192      
Beginning balance at Dec. 31, 2022 296,291 $ 1 539,741 (1,048) (242,403)
Beginning balance, Shares at Dec. 31, 2022   58,221,760      
Stock-based compensation expense 3,263   3,263    
Vesting of early exercised stock options 25   25    
Repurchase of unvested early exercised stock options, Shares   (26,942)      
Unrealized loss on investments in marketable securities 579     579  
Net loss (23,934)       (23,934)
Ending balance at Mar. 31, 2023 276,224 $ 1 543,029 (469) (266,337)
Ending balance, Shares at Mar. 31, 2023   58,194,818      
Beginning balance at Dec. 31, 2022 $ 296,291 $ 1 539,741 (1,048) (242,403)
Beginning balance, Shares at Dec. 31, 2022   58,221,760      
Stock options exercised, shares 55,047        
Net loss $ (79,248)        
Ending balance at Jun. 30, 2023 224,146 $ 1 546,067 (271) (321,651)
Ending balance, Shares at Jun. 30, 2023   57,989,273      
Beginning balance at Mar. 31, 2023 276,224 $ 1 543,029 (469) (266,337)
Beginning balance, Shares at Mar. 31, 2023   58,194,818      
Stock-based compensation expense 2,845   2,845    
Common stock shares issued upon early exercise of options $ 18   18    
Stock options exercised, shares 55,047 55,047      
Repurchase of founders' shares, shares   (152,694)      
Common stock issued under ESPP, Shares   65,222      
Common stock issued under ESPP $ 157   157    
Vesting of early exercised stock options 18   18    
Repurchase of unvested early exercised stock options, Shares   (173,120)      
Unrealized loss on investments in marketable securities 198     198  
Net loss (55,314)       (55,314)
Ending balance at Jun. 30, 2023 $ 224,146 $ 1 $ 546,067 $ (271) $ (321,651)
Ending balance, Shares at Jun. 30, 2023   57,989,273